반응식
CC1C=C(C)N([C:8]([CH:10]2[C:23]3[CH:22]=[CH:21][CH:20]=[CH:19][C:18]=3[O:17][C:16]3[C:11]2=[CH:12][CH:13]=[CH:14][CH:15]=3)=[O:9])N=1.[F:24][C:25]([F:33])([F:32])[C:26]1[O:30][C:29]([NH2:31])=[N:28][N:27]=1>>[F:24][C:25]([F:33])([F:32])[C:26]1[O:30][C:29]([NH:31][C:8]([CH:10]2[C:11]3[CH:12]=[CH:13][CH:14]=[CH:15][C:16]=3[O:17][C:18]3[C:23]2=[CH:22][CH:21]=[CH:20][CH:19]=3)=[O:9])=[N:28][N:27]=1참가 물질
3
실험 절차
The title compound, white solid, m.p. 220-223° C.(decomp.), and MS: m/e=362.2 (M+H+) was prepared in accordance with the general method of example 48a from (3,5-dimethylpyrazol-1-yl)-(9H-xanthen-9-yl)-methanone and 5-trifluoromethyl-[1,3,4]oxadiazol-2-ylamine [U.S. Pat. No. 2,883,391].
출처 및 근거
- ORD 기록
- ord-4d18672260774a608037750e93c12b69
- 출처 데이터셋
- uspto-grants-2002_10
- 특허 번호
- US06462198B1
연결된 노트
불러오는 중…